A Feb. 7 memo from the Office of the Director of the National Institutes of Health (NOT-OD-25-068) announced the decision to implement a flat 15% Facilities and Administrative fee (F&A), also known as an indirect cost rate, ”across all NIH grants.” Public statements from the Association of American Medical Colleges (AAMC), Association of American Universities (AAU), American Council on Education, (ACE) and Association of Public and Land-grant Universities (APLU), among others, outlined their objections to the move, highlighting the impact it would have on medical research.

Answering the question of what impact a flat 15% F&A reimbursement rate would have on the nation’s SBIR startups requires real data. The data doesn’t currently exist that we are aware of. As a result, SSTI invites all SBA FAST recipients, state SBIR matching grant programs, life science-based innovation and commercialization offices, and other interested TBED initiatives to join us for a virtual meeting as we launch a ‘citizen-science based’ online record gathering initiative to help inform state and federal policymakers.  Register here.

President Trump’s nominee to become Secretary of Commerce, Howard Lutnick, cleared the Senate Committee on Commerce, Science and Transportation on Feb. 4 by a vote of 16 to 12. A floor vote is expected soon, possibly still this week. Among the agencies within the Commerce Department are two agencies that support core elements of regional innovation and technology-based economic development more broadly. The National Institutes of Standards and Technology (NIST) oversees the Manufacturing Extension Partnership and the Economic Development Administration, which is one of the largest federally supported of core TBED and economic development efforts around the country. Lutnick’s support of the CHIPS Act and sustaining the current structure of the National Oceanic and Atmospheric Administration (NOAA) remain unclear, according to Roll Call. Lutnick is currently CEO of Cantor Fitzgerald, a Wall Street financial services firm.

In this week’s continuing coverage of gubernatorial addresses as they impact the innovation economy, the following highlights have been selected from three of the eight State of the States or budget addresses given between Jan. 28 and Feb. 5, 2025, by the governors from Indiana, Mississippi, and South Carolina. This is the first address for Indiana's new governor, and it provides evidence of economic development being one of his top priorities. Information on previous 2025 State of the States and/or budget addresses can be found here and here.

The launch of a new private equity firm in central Ohio is a reminder of the continuing ripple effects of a decades-long strategy of cultivating an innovation system. If the State of Ohio hadn’t created and provided sustained funding over decades for its integrated array of technology-based economic development programs, the founders of a newly launched private equity firm wouldn’t be in the position now to commit to helping more mid-market companies succeed in central Ohio.

Readers may have noticed the most populous states end up topping many of the statistical tables related to economic development. Normalizing the data by some relevant, related measure can provide a higher quality look that is a little closer to the “apples to apples” appeal that might help influence some policy issues. For this week’s edition of Useful Stats, SSTI is exploring research intensity as a component of state gross domestic product (GDP) and the research load “carried” by each member of the R&D personnel within the state’s higher education community.

SSTI’s new analysis of NIH data reveals the agency’s external R&D spending per award has been essentially treading water for the past 25 years in terms of real dollars—rising just 4% since FY 2000 when adjusted for inflation. This slow growth comes despite the crucial role NIH funding plays in technology-based economic development (TBED) policies across many states, particularly in the biomedical and life sciences. However, NIH funding remains a major economic driver as the world’s largest funder of biomedical and behavioral research, having generated nearly $2.50 of economic activity for every dollar spent in FY 2023, according to NIH estimates. While these awards support innovation, academic research, and regional economies, their purchasing power has eroded over time, barely keeping pace with inflation.